Together Pharma Statistics

Total Valuation

Together Pharma has a market cap or net worth of ILS 67.43 million. The enterprise value is 127.44 million.

Market Cap	67.43M
Enterprise Value	127.44M

Important Dates

The last earnings date was Thursday, May 29, 2025.

Earnings Date	May 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Together Pharma has 17.35 million shares outstanding. The number of shares has increased by 41.39% in one year.

Current Share Class	17.35M
Shares Outstanding	17.35M
Shares Change (YoY)	+41.39%
Shares Change (QoQ)	+8.40%
Owned by Insiders (%)	54.78%
Owned by Institutions (%)	n/a
Float	7.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.70
PB Ratio	1.76
P/TBV Ratio	7.83
P/FCF Ratio	49.07
P/OCF Ratio	23.67
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.61, with an EV/FCF ratio of 92.75.

EV / Earnings	-108.74
EV / Sales	1.33
EV / EBITDA	12.61
EV / EBIT	38.95
EV / FCF	92.75

Financial Position

The company has a current ratio of 1.07, with a Debt / Equity ratio of 1.66.

Current Ratio	1.07
Quick Ratio	0.35
Debt / Equity	1.66
Debt / EBITDA	6.29
Debt / FCF	46.26
Interest Coverage	0.35

Financial Efficiency

Return on equity (ROE) is -9.09% and return on invested capital (ROIC) is 2.66%.

Return on Equity (ROE)	-9.09%
Return on Assets (ROA)	1.43%
Return on Invested Capital (ROIC)	2.66%
Return on Capital Employed (ROCE)	4.80%
Revenue Per Employee	482,678
Profits Per Employee	-5,889
Employee Count	199
Asset Turnover	0.67
Inventory Turnover	1.41

Taxes

Income Tax	-592,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.68% in the last 52 weeks. The beta is 0.36, so Together Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	-25.68%
50-Day Moving Average	410.42
200-Day Moving Average	429.04
Relative Strength Index (RSI)	39.07
Average Volume (20 Days)	5,305

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Together Pharma had revenue of ILS 96.05 million and -1.17 million in losses. Loss per share was -0.09.

Revenue	96.05M
Gross Profit	17.51M
Operating Income	3.27M
Pretax Income	-2.21M
Net Income	-1.17M
EBITDA	8.93M
EBIT	3.27M
Loss Per Share	-0.09

Full Income Statement

Balance Sheet

The company has 8.44 million in cash and 63.57 million in debt, giving a net cash position of -55.12 million or -3.18 per share.

Cash & Cash Equivalents	8.44M
Total Debt	63.57M
Net Cash	-55.12M
Net Cash Per Share	-3.18
Equity (Book Value)	38.21M
Book Value Per Share	2.41
Working Capital	5.68M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.85 million and capital expenditures -1.48 million, giving a free cash flow of 1.37 million.

Operating Cash Flow	2.85M
Capital Expenditures	-1.48M
Free Cash Flow	1.37M
FCF Per Share	0.08

Full Cash Flow Statement

Margins

Gross margin is 18.23%, with operating and profit margins of 3.41% and -1.22%.

Gross Margin	18.23%
Operating Margin	3.41%
Pretax Margin	-2.30%
Profit Margin	-1.22%
EBITDA Margin	9.30%
EBIT Margin	3.41%
FCF Margin	1.43%

Dividends & Yields

Together Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-41.39%
Shareholder Yield	n/a
Earnings Yield	-1.74%
FCF Yield	2.04%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 13, 2023. It was a reverse split with a ratio of 0.1.

Last Split Date	Aug 13, 2023
Split Type	Reverse
Split Ratio	0.1

Scores

Together Pharma has an Altman Z-Score of -0.94 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.94
Piotroski F-Score	4